[A Case of Esophageal Cancer with Consciousness Disorder Due to Hyperammonemia during FP Treatment].
Gan To Kagaku Ryoho
; 50(4): 493-495, 2023 Apr.
Article
em Ja
| MEDLINE
| ID: mdl-37066465
ABSTRACT
Hyperammonemia induced by 5-fluorouracil(5-FU)is known as a rare adverse event, but there are few reports of hyperammonemia occurring during FP(5-FU plus CDDP)treatment for esophageal cancer. We report a case of esophageal cancer with consciousness disorder due to hyperammonemia during FP treatment with an examination of some of the relevant literature. The patient was a man of approximately 70 years of age who was received FP treatment. He showed consciousness disorder on day 4. A blood test showed hyperammonemia(427µg/dL), which was considered to be the cause of his consciousness disorder. He was treated with branched chain amino acid infusion, lactulose and kanamycin and made a full recovery. An operation for esophageal cancer was performed after 3 months and he is currently followed up without recurrence. Hyperammonemia should be considered as a differential diagnosis of consciousness disorder during chemotherapy including 5-FU.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Esofágicas
/
Hiperamonemia
Idioma:
Ja
Ano de publicação:
2023
Tipo de documento:
Article